Cancer Australia Research Grants
The Leukaemia Foundation is a funding partner of Cancer Australia (CA) – an Australian Government agency that provides grants through its Priority-driven Collaborative Cancer Research Scheme (PdCCRS).
This partnership ensures research supported by the Leukaemia Foundation is high quality and all Australian researchers have the opportunity to apply and receive Leukaemia Foundation research funding.
The PdCCRS funds projects in areas where research priority has been identified by CA and its funding partners.
As a funding partner, the Leukaemia Foundation sets its own research priorities and the categories to be funded in each funding round.
Recent Leukaemia Foundation qualitative research identified the need for ‘early career researchers’ to have access to funding opportunities. These are emerging academics who have been awarded a doctoral degree or other postgraduate qualification in the last five years.
Nurturing ‘early career’ medical researchers is critical to discovering better and safer blood cancer treatments and keeping the most promising and exciting talent in Australia.
Our research investment supports post-doctoral researchers with 1-3 years post-doctoral experience or post-MBBS qualifications; and post-doctoral researchers with 4-7 years post-doctoral experience or post-MBBS qualifications.
Our 2018 funding priorities are:
- Myeloma – 2 one-year projects
- Myelodysplastic syndrome – a one-year project
- Paediatric acute lymphoblastic leukaemia – a one-year project
- Blood cancer – 2 two-year projects
Total funding for these CA research grants in 2018/19 is $800,000.
CA uses the National Health and Medical Research Council (NH&MRC) research grants management system.
Applications for 2018 closed in March and are currently going through two rounds of assessment:
- Grants assessed and ranked according to the NH&MRC grants peer review process.
- Applications assessed by CA against outcomes and impact, translatability, collaborations, and consumer involvement.
The top ranked projects are offered funding. Successful applicants for the 2018 round of funding will be awarded in December 2018, with research to start in January/February 2019.
The CA partnership also provides an opportunity for funds gifted to the Leukaemia Foundation for disease-specific research, be directed towards high quality research, and for grants to be co-funded with CA.
Developed by the Leukaemia Foundation in consultation with people living with a blood cancer, Leukaemia Foundation support staff, haematology nursing staff and/or Australian clinical haematologists. This content is provided for information purposes only and we urge you to always seek advice from a registered health care professional for diagnosis, treatment and answers to your medical questions, including the suitability of a particular therapy, service, product or treatment in your circumstances. The Leukaemia Foundation shall not bear any liability for any person relying on the materials contained on this website.